Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)
- PMID: 33427657
- DOI: 10.1016/j.ijrobp.2020.09.022
Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC)
Erratum in
-
Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC) Int J Radiat Oncol Biol Phys 2020;108:1399-1400.Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):698. doi: 10.1016/j.ijrobp.2023.01.025. Int J Radiat Oncol Biol Phys. 2023. PMID: 37270256 No abstract available.
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
